FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4149611000001108: Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26399101000001110 Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26399201000001115 Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Is a Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Is pack of Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has active ingredient Lanreotide acetate false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has active ingredient Lanreotide acetate false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has AMP Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has specific active ingredient Lanreotide acetate true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start